Selway Capital Acquisition Corporation Announces New Trading Symbol
NEW YORK, Sept. 9, 2013 /PRNewswire/ -- Selway Capital Acquisition Corporation (OTC: SWEL) ("Selway") today announced that the new class of common stock created by the consolidation of Selway's Series B shares of common stock and Series C shares of common stock into a single class of common stock will trade under the new trading symbol SWEL. Selway expects its common stock to begin trading under the new trading symbol as of the beginning of trading today, September 9, 2013.
About Selway Capital Acquisition Corporation
Following the consummation of Selway's acquisition of Healthcare Corporation of America ("HCCA") on April 10, 2013, Selway operates through HCCA. Based in Denville, N.J., HCCA's (http://www.hccarx.com) mission is to reduce prescription drug costs for clients while improving the quality of care for its members. Through its pharmacy benefit management (PBM) subsidiary, Prescription Corporation of America, HCCA administers prescription drug benefit programs for employers ranging from commercial clients of various sizes and industries to business associations and trade groups, as well as local government entities, labor unions, charitable and non-profit organizations, and third-party administrators of self-insured benefit plans. In addition, through its 340Basics subsidiary (www.340Basics.com), HCCA provides software and services to help Covered Entities manage all processes related to the Federal 340B Drug Discount Program including registration, compliance, audit, claims processing, and access to pharmacies.
Contact: Yoram Bibring, Chief Financial Officer
(973) 983-6300
SOURCE Selway Capital Acquisition Corporation
Share this article